VEGFA and colorectal carcinoma: In contrast, by utilizing the lead cis-eQTL as an instrumental variable to study VEGF R1, we observed a reduction in the risk of CRC (OR (95% CI) = 0.81 (0.71–0.93), P = 2.1E-3).